tiprankstipranks
Innovent Biologics (MX:1801N)
:1801N
1801N
Innovent Biologics
RESEARCH TOOLSreports

Innovent Biologics (1801N) Revenue

1 Followers
StatisticsMarket CapRevenue

Innovent Biologics Revenue

Innovent Biologics had a revenue of 8.50B in the quarter ending Jun 30, 2026, with 19.90%. This bring the company's revenue in the last twelve months to 15.59B, Decreased 19.52%. In the fiscal year ending Dec 31, 2025, Innovent Biologics had annual revenue of 13.04B with 38.42% growth.
Revenue (ttm)
15.59B
Revenue Growth
29.01%
P/S Ratio
29.52
Revenue/Employee
$1,489,779
Employees
8,754
Market Cap
$384.96B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
13.04B3.62B+38.42%
Dec 31, 2024
9.42B3.22B+51.82%
Dec 31, 2023
6.21B1.65B+36.21%
Dec 31, 2022
4.56B286.65M+6.71%
Dec 31, 2021
4.27B425.91M+11.08%
Dec 31, 2020
3.84B2.80B+266.94%
Dec 31, 2019
1.05B1.04B+10,953.34%
Dec 31, 2018
9.48M-9.06M-48.88%
Dec 31, 2017
18.54M――